trividia
Acquired1 known investors
Trividia Health is a Florida-based medical device maker of TRUE-brand blood glucose monitoring systems and diabetes care products.
Also known as Nipro Diagnostics · Trividia Health · Trividia Health, Inc.
Investors · 1
Company profile
researched Aug 2026Trividia Health, Inc. is a global medical device company focused on diabetes care, headquartered at 2200 West Cypress Creek Road in Fort Lauderdale, Florida. It develops, manufactures and markets blood glucose monitoring systems and related supplies, most prominently the TRUE family of products, including the TRUE METRIX system and the TRUE METRIX AIR Bluetooth-enabled meter, along with the proprietary TRUEmanager diabetes management software for uploading, transmitting and logging glucose data. Beyond meters and test strips, the portfolio spans sharps products such as lancing devices, insulin syringes and pen needles, as well as nutrition and skincare products aimed at people with diabetes; the company has built a line of more than 40 products over roughly three decades.
The business was formerly known as Nipro Diagnostics, a Fort Lauderdale developer and manufacturer of diabetes products including glucose monitors. Chinese diabetes-care company Sinocare acquired the diagnostics business from Nipro (TYO: 8086) for $273 million in a deal first announced in October 2015 and closed in early 2016, renaming it Trividia Health. Scott Verner, formerly CEO and chair of Nipro Diagnostics, continued as president and CEO along with key members of the management team, and the company retained its U.S. location. A related entity, Trividia Manufacturing Solutions, Inc., operates as a contract manufacturer of OTC drugs, dietary supplements, homeopathics, cosmetics, animal feed supplements and dosage-form animal health products, offering formulation batching, testing, packaging, labeling and shipping services.
Business model
Trividia Health develops, manufactures and markets diabetes-management medical devices and consumables, selling its own TRUE-branded products alongside co-branded blood glucose monitoring systems produced for retail chains and mail-service providers. Recurring consumable sales of test strips and lancets accompany meter placements. Its Trividia Manufacturing Solutions arm operates a contract manufacturing model, batching and packaging customer formulas across liquids and tablets.
Revenue derives from sales of blood glucose meters, test strips, lancing devices, insulin syringes, pen needles, nutrition and skincare products through retail drug stores, online stores, mail-order providers and medical supply distributors, both under the TRUE brand and under retailer private-label brands, plus contract manufacturing services.
Traction
Over 2.5 million active patients in the United States use Trividia Health products, which are carried by retail drug chains including Walgreens, CVS and Rite Aid as well as regional and independent pharmacies and mail service providers. A third-party profile lists estimated annual revenue of $350 million and 101-200 employees.
Latest developments
Trividia Health continues to market its TRUE family of blood glucose monitoring systems and accessories through retail, online, mail-order and distributor channels, and maintains an important product notice on its consumer site. Its TRUE METRIX AIR meter is offered as a cellular-connected remote patient monitoring device through Tenovi. Trividia Manufacturing Solutions continues to operate as a contract manufacturer across liquids and tablets. The company has said it planned to launch a service enabling pharmacies and pharmacy clinics to work with patients' providers to manage drug regimens for people with diabetes.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
The company describes itself as a leading supplier of co-branded blood glucose monitoring systems to retailers throughout North America with a growing international customer base, drawing on more than 30 years of operating experience. It reports over 2.5 million active patients using its products in the United States. MedTech Outlook Magazine named Trividia Health among its "Top 20 Medtech Providers companies - 2021."
Trividia Health positions itself as a one-stop supplier for diabetes care, pairing monitoring hardware and data software with sharps, nutrition and skincare lines, and emphasizes low-cost, affordable and user-friendly devices. It operates a dedicated New Hampshire facility producing nutrition and skincare products formulated for people with diabetes, acquired from a long-established nutrition manufacturer and reformulated for taste, color and texture.
Technology
The TRUE METRIX blood glucose monitoring system supports extensive event tagging (meal, exercise and wellness markers) to track health trends, and the TRUE METRIX AIR variant transmits results via Bluetooth so patients can share data with clinicians. TRUEmanager software enables data upload, transmission and online logbook recording. The TRUE METRIX AIR meter is FDA-cleared, uses a no-coding method, a 0.5 microliter sample, a 4-second test time and a 20-600 mg/dL measurement range, with reported accuracy of 99.0% within +/-15 mg/dL, 87.0% within +/-10 mg/dL and 64.0% within +/-5 mg/dL. Manufacturing is subject to quality control processes aligned with the products cleared under FDA 510(k).
Go-to-market
Products reach consumers through retail pharmacy chains including Walgreens, CVS and Rite Aid, regional and independent pharmacies, mail service providers, online stores and medical-surgical distributors, with co-branded private-label programs for retailers. The company also markets to healthcare professionals and supports remote patient monitoring deployments; the TRUE METRIX AIR meter is resold as a cellular-connected RPM device by Tenovi, which bills under Medicare RPM CPT codes.
People with diabetes in the United States and international markets, plus healthcare professionals, pharmacies and pharmacy clinics, retailers and distributors, and remote patient monitoring providers. Contract manufacturing customers include companies in dietary supplements, OTC pharmaceuticals, nutraceuticals, personal care, homeopathics and veterinary products.
Geography
Corporate headquarters in Fort Lauderdale, Florida, with manufacturing facilities in New Hampshire, Florida and Taiwan. Products are sold across North America and to international markets; the consumer website is directed at United States visitors with country selection for other regions.
History
The business was founded in 1985 and built its core operations around manufacturing blood glucose meters and test strips, expanding to a line of more than 40 products over three decades. Operating as Nipro Diagnostics under Japanese parent Nipro, it was sold to Sinocare in a $273 million transaction announced in October 2015 and closed in 2016, at which point it was renamed Trividia Health, retaining CEO Scott Verner and its U.S. operations. At an earlier point the company acquired a long-established nutrition manufacturer, giving it a New Hampshire facility for nutrition and skincare products.
Risks & controversies
The company's consumer website carries a prominent "Important Product Notice" directing visitors to further information.
Compiled by commissioned research from 7 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 4
launches, deals, and filingsTrividia Health acquired a century-old nutrition company, giving it a New Hampshire facility dedicated to producing nutrition and skincare products for people with diabetes; products were subsequently reformulated for taste, color and texture.
MedTech Outlook Magazine recognized Trividia Health as a recipient of its Top 20 Medtech Providers companies award for 2021, based on the publication's proprietary methodology.
Nipro closed the $273 million sale of its diagnostics business to Sinocare, which renamed the acquired company Trividia Health. Former Nipro Diagnostics CEO and chair Scott Verner stayed on as president and CEO with key executives from the management team, and the company retained its U.S. location.
$273M source ↗
Nipro (TYO: 8086) first announced the sale of Nipro Diagnostics to China-based Sinocare; as part of the deal Nipro said it would continue to purchase certain products in agreed-upon markets from Sinocare.
$273M source ↗
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 7
primary sources listed
- Home - Trividia Healthtrividiahealth.com · web
7 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does trividia do?
- Trividia Health is a Florida-based medical device maker of TRUE-brand blood glucose monitoring systems and diabetes care products.
- Who are trividia's investors?
- trividia's investors include Access Venture Partners.
